Nivalis Therapeutics, Inc. 4
4 · Nivalis Therapeutics, Inc. · Filed Sep 15, 2015
Insider Transaction Report
Form 4
Furst Howard P.
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-09-11+7,650→ 7,650 totalExercise: $15.28Exp: 2025-09-11→ Common Stock (7,650 underlying)
Footnotes (2)
- [F1]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F2]The shares shall vest in 12 equal monthly installments commencing on October 11, 2015.